5858 HORTON STREET #455, EMERYVILLE, CA
Market cap: $463.2M (2/08/2026)
Price: $9.08
4D Molecular Therapeutics Issues Pre-Funded Warrants for Common Stock
4D Molecular Therapeutics Reports $514 Million in Cash Position
Other Events
Kristian Humer Appointed CFO of 4D Molecular Therapeutics, Inc.
Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
4D Molecular Therapeutics Issues 8.39M Shares at $10.51 Each
4D Molecular Therapeutics Reports $372.2 Million in Cash as of September 30, ...
Collaboration Agreement with Otsuka for 4D-150 in APAC Markets
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Post-Effective Amendment to Registration Statement